Raphaël Saffroy

2.8k total citations
79 papers, 1.8k citations indexed

About

Raphaël Saffroy is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Raphaël Saffroy has authored 79 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Raphaël Saffroy's work include Glioma Diagnosis and Treatment (13 papers), Cancer Genomics and Diagnostics (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Raphaël Saffroy is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Cancer Genomics and Diagnostics (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Raphaël Saffroy collaborates with scholars based in France, United States and United Kingdom. Raphaël Saffroy's co-authors include Antoinette Lemoine, Brigitte Debuire, Daniel Azoulay, Patrick Pham, Mylène Sebagh, J. HAMELIN, Francine Rendu, Christilla Bachelot‐Loza, Nelly Bosselut and Henri Bismuth and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Oncogene.

In The Last Decade

Raphaël Saffroy

70 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphaël Saffroy France 27 559 491 343 330 288 79 1.8k
Margret Rave‐Fränk Germany 25 732 1.3× 665 1.4× 395 1.2× 216 0.7× 343 1.2× 89 1.9k
Jonathan H. Axelrod Israel 25 919 1.6× 416 0.8× 149 0.4× 237 0.7× 367 1.3× 45 2.2k
Martin Volkmann Germany 24 595 1.1× 582 1.2× 133 0.4× 435 1.3× 155 0.5× 41 2.0k
Min Ren United States 21 330 0.6× 406 0.8× 322 0.9× 216 0.7× 206 0.7× 80 1.7k
Michele Quaranta Italy 24 596 1.1× 644 1.3× 198 0.6× 203 0.6× 457 1.6× 57 1.6k
Fan Lin United States 24 1.6k 2.9× 680 1.4× 411 1.2× 343 1.0× 414 1.4× 69 2.7k
Alexander Fuchs United States 20 550 1.0× 457 0.9× 301 0.9× 72 0.2× 264 0.9× 60 1.7k
Yasuo Hirono Japan 23 616 1.1× 505 1.0× 410 1.2× 159 0.5× 254 0.9× 112 1.7k
Yoriaki Kaneko Japan 26 529 0.9× 290 0.6× 250 0.7× 119 0.4× 112 0.4× 91 2.6k

Countries citing papers authored by Raphaël Saffroy

Since Specialization
Citations

This map shows the geographic impact of Raphaël Saffroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Saffroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Saffroy more than expected).

Fields of papers citing papers by Raphaël Saffroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Saffroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Saffroy. The network helps show where Raphaël Saffroy may publish in the future.

Co-authorship network of co-authors of Raphaël Saffroy

This figure shows the co-authorship network connecting the top 25 collaborators of Raphaël Saffroy. A scholar is included among the top collaborators of Raphaël Saffroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphaël Saffroy. Raphaël Saffroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tauziède‐Espariat, Arnault, Philipp Sievers, Volodia Dangouloff‐Ros, et al.. (2025). Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome. Acta Neuropathologica Communications. 13(1). 8–8. 1 indexed citations
2.
Pagès, Mélanie, Marie‐Anne Debily, Fréderic Fina, et al.. (2022). The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases. Neuropathology and Applied Neurobiology. 48(6). e12834–e12834. 3 indexed citations
3.
Jacot, William, Evelyne Lopez‐Crapez, Caroline Mollévi, et al.. (2020). BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer. Cancers. 12(4). 828–828. 28 indexed citations
4.
Bouchahda, Mohamed, Raphaël Saffroy, Abdoulaye Karaboué, et al.. (2020). UndetectableRAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients WithRAS-Mutant Metastatic Colorectal Cancer. JCO Precision Oncology. 4(4). 1070–1079. 22 indexed citations
5.
Machover, D., Luigia Rossi, J. HAMELIN, et al.. (2019). Effects in Cancer Cells of the Recombinant L-Methionine Gamma-Lyase from Brevibacterium aurantiacum. Encapsulation in Human Erythrocytes for Sustained L-Methionine Elimination. Journal of Pharmacology and Experimental Therapeutics. 369(3). 489–502. 23 indexed citations
6.
Ruiz, Aldrick, Mylène Sebagh, Raphaël Saffroy, et al.. (2019). Chronological occurrence of PI3KCA mutations in breast cancer liver metastases after repeat partial liver resection. BMC Cancer. 19(1). 169–169. 4 indexed citations
7.
Saffroy, Raphaël, Geneviève Lafaye, Christophe Desterke, et al.. (2018). Several clock genes polymorphisms are meaningful risk factors in the development and severity of cannabis addiction. Chronobiology International. 36(1). 122–134. 12 indexed citations
8.
Ruppert, Anne-Marie, Martine Antoine, Nicolas Girard, et al.. (2018). c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas. Journal of Thoracic Oncology. 13(12). 1962–1967. 46 indexed citations
9.
Zanello, Marc, Mélanie Pagès, Arnault Tauziède‐Espariat, et al.. (2016). Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma. Journal of Neuropathology & Experimental Neurology. 75(10). 971–980. 34 indexed citations
10.
Pagès, Mélanie, Kévin Beccaria, Nathalie Boddaert, et al.. (2016). Co‐occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. Brain Pathology. 28(1). 103–111. 72 indexed citations
11.
Saffroy, Raphaël, et al.. (2016). Métastases mammaires des cancers bronchopulmonaires avec mutation de l’EGFR. Revue des Maladies Respiratoires. 34(1). 61–65.
12.
Saffroy, Raphaël, et al.. (2016). Ultra-sensitive mass spectrometry allows 33% increased detection of somatic EGFR T790M mutation in plasma cfDNA samples. Annals of Oncology. 27. vi18–vi18. 1 indexed citations
13.
Fallet, Vincent, Raphaël Saffroy, Nicolas Girard, et al.. (2015). High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets. Annals of Oncology. 26(8). 1748–1753. 74 indexed citations
14.
Saffroy, Raphaël, Antoinette Lemoine, & Brigitte Debuire. (2011). CDKN2a (cyclin dependent kinase 2a / p16). Atlas of Genetics and Cytogenetics in Oncology and Haematology.
15.
Benyamina, Amine, Raphaël Saffroy, Lisa Blecha, et al.. (2009). BRIEF REPORT: Association between MTHFR 677C‐T polymorphism and alcohol dependence according to Lesch and Babor typology. Addiction Biology. 14(4). 503–505. 11 indexed citations
16.
Tabone‐Eglinger, Séverine, Agnieszka Woźniak, Raphaël Saffroy, et al.. (2005). KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1741(1-2). 165–172. 32 indexed citations
17.
Saffroy, Raphaël, et al.. (2004). Biologie moléculaire et carcinome hépatocellulaire : données actuelles et développements futurs. Annales de biologie clinique. 62(6). 649–656. 8 indexed citations
18.
19.
20.
Drané, Pascal, et al.. (2002). Accumulation of an inactive form of p53 protein in cells treated with TNFα. Cell Death and Differentiation. 9(5). 527–537. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margret Rave‐Fränk Breakdown of academic impact, for papers by Jonathan H. Axelrod Breakdown of academic impact, for papers by Martin Volkmann Breakdown of academic impact, for papers by Min Ren Breakdown of academic impact, for papers by Michele Quaranta Breakdown of academic impact, for papers by Fan Lin Breakdown of academic impact, for papers by Alexander Fuchs Breakdown of academic impact, for papers by Yasuo Hirono Breakdown of academic impact, for papers by Yoriaki Kaneko
Rankless by CCL
2026